LER & CER: letter to Editor Rheumatology
Baricitinib plus leflunomide: a potentially dangerous combination?
D. Reffat1, A. O'riordan2, F. Adeeb3
- Department of Rheumatology, University Hospital Kerry, Ireland.
- Department of Rheumatology, University Hospital Kerry, Ireland.
- Department of Rheumatology, University Hospital Kerry, Ireland. fahd_adeeb@yahoo.com
CER14320
2021 Vol.39, N°1 ,Suppl.128
PI 0031, PF 0032
LER & CER: letter to Editor Rheumatology
Free to view
(click on article PDF icon to read the article)
PMID: 33634779 [PubMed]
Received: 12/12/2020
Accepted : 02/02/2021
In Press: 19/02/2021
Published: 19/02/2021